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Surfactant therapiesPulmonary surfactant (PS) is a surface active complex of lipids and proteins that prevents the alveolar structures
from collapsing and reduces the work of breathing by lowering the surface tension at the alveolar air–liquid
interface (ALI). Surfactant is synthesized by the alveolar type II (AT II) cells, and it is stored in specialized organ-
elles, the lamellar bodies (LBs), as tightly packed lipid bilayers. Upon secretion into the alveolar lining ﬂuid, a
large fraction of these particles retain most of their packed lamellar structure, giving rise to the term lamellar
body like-particles (LBPs). Due to their stability in aqueous media, freshly secreted LBPs can be harvested from
AT II cell preparations. However, when LBPs get in contact with an ALI, they quickly and spontaneously adsorb
into a highly organized surface ﬁlm. In the present study we investigated the adsorptive capacity of LBPs at an
ALI under relevant physiological parameters that characterize the alveolar environment in homeostatic or in
pathological conditions. Adsorption of LBPs at an ALI is highly sensitive to pH, temperature and albumin concen-
tration and to a relatively lesser extent to changes in osmolarity or Ca2+ concentrations in the physiological
range. Furthermore, proteolysis of LBPs signiﬁcantly decreases their adsorptive capacity conﬁrming the
important role of surfactant proteins in the formation of surface active ﬁlms.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Due to mammalian lung's speciﬁc design, containing millions of
small alveolar chambers, pulmonary surfactant (PS) is crucial to stabi-
lize this structure and to support its genuine respiratory functions. PS
is synthesized and secreted by the alveolar type II (AT II) cells [19].
Released surfactant material is quickly adsorbed at the air–liquid inter-
face (ALI) in order to lower surface tension of the alveolar lining
ﬂuid (ALF) and, according to recent ﬁndings, to favor oxygen diffusion
[42,44,45]. Thereby, the integrity of the lung and the respiratory
interface is maintained and an alveolar collapse avoided.
PS is a lipid–protein complex composed of 80% phospholipids (half
of which is disaturated dipalmitoylphosphatidylcholine; DPPC), 10%
neutral lipids (mainly cholesterol) and approximately 10% surfactant
proteins [19,64]. After the synthesis and proper processing of the differ-
ent protein and lipid components through the endoplasmic reticulum
and the Golgi apparatus, surfactant complexes are ﬁnally assembled
and stored in characteristic subcellular compartments known as lamel-
lar bodies (LBs). LBs are lysosome-derived secretory organelles with a
diameter of up to ~2 μm (in humans and rodents) [41,54,64], and
constitute ~20% of the cytosolic AT II cell volume [22,54]. In several
studies it has been shown that PS, during and after release, maintains
much of its packed structure unless contacting the ALI. Consequently,these surfactant particulate entities were termed LB like-particles
(LBPs) to underscore this morphological similarity with the
intracellular surfactant storage form (LBs). LBPs exhibit a spontaneous
disintegration upon contact with the ALI, leading to an immediate
spreading of material and a decline of surface tension to values
below 30 mN/m followed by a further reduction in the lung close to
1–2 mN/m, probably due to ﬁlm reﬁnement during ﬁlm compression
[25,50,58].
Changes in the lung environment caused by physiological stress
factors and during various pathophysiological conditions, e.g. inﬂam-
matory processes, respiratory/metabolic alkalosis or acidosis, hypo- or
hyperthermia, airway drying or osmotic stress caused by edema forma-
tion, hyperventilation or swallowing of noxious ﬂuids, may all alter the
surfactant's functional properties. Naturally, we assume that most of
these changes will lead to impairment or loss of surfactant function
rather than to its improvement. Those impaired functions will entail,
by deﬁnition, a high surface tension at the ALI and, further on, may
lead to a reduction in the lung compliance and functional residual
capacity [3,23]. They even may cause hypoxemia and hypercapnia and
may contribute to numerous serious lung syndromes involving diffuse
alveolar damage (DAD), ventilation induced lung injury (VILI), acute
lung injury (ALI) and other critical acute respiratory distress syndromes
(ARDS) that are often observed in mechanically ventilated patients and
newborn babies [22,23]. However, a systematic investigation of all
physiological parameters that may be subject to changes is lacking,
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biophysical measurements to a large amount of samples and variables.
One well known cause of surfactant inactivation is the presence of
plasma proteins, which can leak from the lung capillaries into the
alveolus and compete with surfactant phospholipids at the ALI. For in-
stance, in ARDS, albumin concentrations may reach up to 100 mg/ml,
with ameanvalue of 25 mg/ml [31], whereas in vitro and in vivo studies
conﬁrmed that even much lower protein concentrations may cause
severe interruption of the pressure–volume (P–V) mechanics in rat
lungs [27,62,65]. Inhibition by plasma proteins has been sought to be
reverted or at least partially ameliorated by administration of various
exogenous surfactant preparations, though the outcome of these
investigations did not unambiguously lead a clear result [23].
This exogenous surfactant material is prepared from natural surfac-
tant isolated from animal lungs by a series of lipid extraction steps with
organic solvents. Through this harsh puriﬁcation procedure hydrophilic
proteins like SP-A and SP-D are removed and the obtained material
contains only lipids and small amounts of the hydrophobic proteins
SP-B and SP-C. For example Curosurf, a widely used exogenous surfac-
tant extracted from minced porcine lungs, contains a signiﬁcantly
lower concentration of DPPC and biophysically active proteins like
surfactant proteins B and C (SP-B, SP-C) than native surfactant, and no
SP-A [9]. Such, ‘lipid extract’ is unable to generate tubular myelin, a
membrane-based lattice-like surfactant structure, which has been
proposed to act as intermediate in alveolar surfactant turnover [56].
However, Curosurf adsorbs rapidly to an ALI, effectively spreads in the
airspaces, is physiologically functioning in vitro and in vivo [21,52],
and its administration to newborns suffering from IRDS signiﬁcantly
decreased their mortality [9,52]. In the same line, knock-out mice
models lacking expression of the SP-A gene lack tubular myelin but
breath normally [32], suggesting that tubular myelin is not a necessary
intermediate but possibly a reservoir of surface active material [44].
The successful response to surfactant therapy depends primarily on
the timing of treatment in relation to the clinical course and the mode
of delivery. Secondary, the quality of the exogenous material is crucial
for a successful application. This quality mainly depends on the chemical
composition of the surfactant but might be inﬂuenced by the physiolog-
ical state of the patients lung, (e.g. hypo- or hyperthermia during anes-
thesia or fever, increase of serum due to lung injury, exogenous/
endogenous airways acidiﬁcation, etc.) as well. Several attempts have
been made to improve the known surfactant replacement therapies,
however, regarding the interfacial adsorption, exogenous surfactants
currently in clinical trials have been proven to be less efﬁcient than
endogenous surfactant, particularly in the presence of inhibitory
compounds [10,11,62]. Reasons for this reduced functionality are still
unclear, but are likely related with differences in composition and struc-
ture. In vitro and in vivo studies emphasize the importance of standard-
ized protocols for the assessment of therapeutic surfactants, and suggest
that surfactant function strongly depends on the physiological environ-
ment [9].
In this paper we analyzed how the adsorptive behavior of LBPs that
have been collected from cell cultures of primary rat AT II cells is affected
by physical and chemical parameters like Ca2+ concentration, osmotic
strength, pH, temperature and protein concentration. LBPs, in contrast
to extracted surfactant, are likely to contain the full complement of
various proteins and lipid species as assembled and secreted by the
pneumocytes. In particular, Western blot analysis demonstrated the
presence of SP-A, SP-B and SP-C in LBPs collected from pure AT II cell
cultures [50]. The application of a mid-high throughput ﬂuorescence-
based assay developed in our laboratories has proven to be particularly
useful to assess a relatively large number of ultra-small sample volumes
as it is the case for LBPs, which can be collected from the cells in a μg
amount only and preclude, due to this quantitative limitation, a multi-
parametric analysis by e.g. captive bubble surfactometry. Although this
assay does not allow assessing the behavior of surfactant ﬁlms during
repeated compression–expansion cycles, it permits, however, a detailedassessment of the formation and stability of the surface associated surfac-
tant reservoir. The study advances to provide awidened understanding of
the biophysical mechanisms of LBPs adsorption process at the ALI, and
how this process is governed by factors in the ALF, whose composition
and physical state is not precisely known. This knowledge, beside its
relevance in lung physiology and pathophysiology, may also have some
implications in the design and application of new surfactant compositions
and surfactant therapies.2. Material and methods
2.1. Reagents
Phospholipase D from streptomyces chromofuscus, Brilliant Black
(BB), salts and chemicals were purchased form Sigma (Sigma-Aldrich,
Germany). High purity bovine serumalbumin (BSA, albumin bovine Frac-
tion V receptor grade lyophilized) was purchased from SERVA (SERVA
Electrophoresis, Germany), BODIPY-PC 2-(4,4-diﬂuoro-5,7-dimethyl-
4-bora-3a,4a-diaza-s-indacene-3-dodecanoyl)-1-hexadecanoyl-sn-
glycero-3-phosphocholine, and Amplex Red Phospholipase D Kit from
Invitrogen (Invitrogen, Austria).2.2. Test solutions and conditions
Control solution (ctrl): For the control conditions we used
standard Ringer Solution containing (in mM): 140 NaCl, 5 KCl, 1
MgCl2, 2 CaCl2, 10 HEPES, pH 7.4. pH solutions: The pH of the sub-
phases were adjusted by titrating NaOH and HCL into the control
solution. The pH values were measured before every experiment
with a digital pH meter (WTW Austria). Calcium solutions: The
control solution was adjusted to the indicated CaCl2 concentrations
(0–5 mM), by addition of CaCl2. The zero Ca2+ solution was made
by using 0 mM CaCl2 + 2 mM EGTA, pH 7.4. Hyper–hypotonic
solutions (in mM): ~600 mOsm solution = 240 NaCl, 10 KCl, 2
MgCl2, 4 CaCl2, 20 HEPES; ~300 mOsm solution = ctrl solution;
~150 mOsm solution = 70 NaCl, 2.5 KCl, 0.5 MgCl2, 1 CaCl2, 5
HEPES; and ~20 mOsm solution = 10 NaCl, 0.357 KCl, 0.071
MgCl2, 0.142 CaCl2, 0.714 HEPES, pH 7.4. Final osmolarity was
checked with an osmometer (Wescor, United States). Temperature
control: Experimental solutions and 96-wells were pre-heated/
cooled and multiplate reader settings were adjusted to the indicat-
ed temperatures (15 °C, 25 °C, 30 °C, 37 °C, 42 °C). Each T-point
was measured individually in a single experiment. Protein solu-
tions: BSA was diluted in the control solution to the indicated con-
centrations (0–2.5 mg/ml BSA).2.3. Surfactant preparations
LBPs were harvested from the supernatants of puriﬁed rat AT II cells
grown on petri dishes (Ø 10 cm) in high density. AT II cells were isolated
from Sprague–Dawley rats as described elsewhere [24]. After two days
in culture, these cells were washed two times with PBS and these cells
were stimulated for 4 h at 37 °C in 4 ml bath solution containing ATP
(100 μM), PMA (500 nM) and Ionomycin (1 μM) supplemented with
antibiotics as previously described. After stimulation, supernatants con-
taining exocytosed surfactant rich in LBPs were collected and stored at
−20 °C until use. As shown by ﬂuorescence microscopy in Fig. 1a,
LBPs are present as a suspension of variably sized, partially unfolded
but globular structures throughout, consistentwith recent TEM analysis
[50]. According to earlier investigations by our group, the size and com-
pactness of these particles remain essentially stable over time [25].
Tubular myelin, a surfactant intermediate with a still undeﬁned role
[44]was not detectable in our preparations, neither by lightmicroscopy
nor by TEM [25,50].
Fig. 1.Measurement of interfacial adsorption and accumulation of LBPs. a) Suspension of LBPs viewed by a lipophilic ﬂuorescent probe (FM 1–43, 470 nmEX., N510 nmEM.). LBPs appear
as compact or partially unraveled globular particles. b) Typical raw ﬂuorescence data as obtained by the adsorption assay (details see text). Time zero corresponds to background
measurement (wells with BB before addition of Bodipy labeled LBPs). c) Explanation of measurement principle. Transparent: wells contain Bodipy (light green) + LBPs (dark green
circles) w/o BB. This control was necessary to test and to eventually correct for unspeciﬁc effects (e.g. various buffer pH values) on the intrinsic ﬂuorescence intensity of Bodipy. Start:
corresponds to the second time point in b, directly after addition of Bodipy labeled LBPs. End: Plateau phase in b with stable surface associated ﬁlm (green). EX, excitation, and EM,
emission (both from top). d) Data representation. Background corrected RFU values (RFU-Bg) are shown for the start and endpoints, respectively.
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Phospholipid concentration of the supernatants was measured by a
lipid chloroform/methanol extraction protocol followed by choline
determination using a coupled enzymatic reaction according to pub-
lished references [35], with slightmodiﬁcations: For the lipid extraction
we used 250 μl sample (LBPs) and added 940 μl chloroform/methanol
(1:2) solution, followed by a strong vortex step (1 min). Afterwards,
310 μl chloroform was added and samples were subsequently
mixed by short vortexing. Finally, 310 μl of distilled water was added
and again intensely mixed (vortexing). Samples were centrifuged for
10 min at 13,000 rpm, and subsequently the lower organic phase con-
taining the lipids was extracted and ﬁlled in fresh vials. Samples were
dried overnight in the hood. Next day, α-lecithin standards and dried
samples were rediluted in reaction buffer of the Amplex Red Phospholi-
paseDAssayKit (Invitrogen) and thereafter 100 μl of the diluted samples/
standardswasmixedwith 100 μl reactionmix containing: phospholipase
D 1 U/ml, choline oxidase 0.2 U/ml, horseradish peroxidase 2 U/ml, and
Amplex Red 100 μM. Samples were measured in a 96-well plate in a
multiplate reader (TECAN M200pro, Tecan, Switzerland) by using
590 nm± 20, 540 ± 9 nm for excitation and emission, respectively.
2.5. Surfactant labeling
BODIPY-PC was dissolved in DMSO to yield a concentration of
1 mg/ml. LBPs were stained by incubation with BODIPY-PC at 37 °C
for 2 h to obtain a ﬁnal molar ratio of 4% (dye/surfactant) [48].
2.6. Adsorption kinetics
Experiments were performed using an assay system speciﬁcally
designed to evaluate interfacial adsorption of LBPs. Moreover, it has
been used to compare adsorption of LBPs with standard surfactant
materials like Curosurf and native surfactant puriﬁed from porcine
lungs. It provides a direct readout of the amount of surfactant reaching
the interface but also of the material, which stably associates with the
forming interfacial ﬁlm. This method is described in detail in a previous
publication [48]. Brieﬂy, the wells of a 96-well microplate (sterile, ﬂat,
transparent Cat.# 655185, Greiner, Germany) were ﬁlled with 100 μl
of a solution containing 5 mg/ml Brilliant Black as a photoquencher,
adjusted to the conditions of interest (pH, Ca2+, osmotic strength, tem-
perature and albumin concentration; Fig. 1).
The plate, without lid, was inserted into the microplate reader
(TECAN GENios Plus, Switzerland) and all measurements were done
using 485 ± 9 nm and 540 ± 9 nm with following standard settings:number of ﬂashes 3, lag time 0 μs, and integrations time 1000 μs for
excitation and emission, respectively, on the top reading mode
(i.e. ﬂuorescence excitation and emission is performed from the top
of the wells). Firstly, unspeciﬁc effects of the test variables (pH, Ca2+,
osmotic strength, temperature, albumin concentration) on the intrinsic
BODIPY-PC ﬂuorescence were evaluated by measuring, in a separate
plate row, the 4% BODIPY-PC loaded LBPs in the respective transparent
bath solution (Fig. 1c, transparent). Secondly, one background measure-
ment (Brilliant Black only), was obtained (Fig. 1b, time 0). Thirdly, the
96-well platewasmovedout and0.5 μgof 4%BODIPY-PC (dye/surfactant)
labeled surfactant was injected into the bulk solution of the wells. There-
after, a kinetic cycle of ﬂuorescence measurements was started for one
hour (cycle time = 1min, orbital shaking = 30 s). Fluorescently labeled
surfactant distributed within the well by orbital shaking, and was ﬁnally
irreversibly (because resistant to intermittent orbital shaking) adsorbed
into the ALI, where the ﬂuorescence signal was detected and quantiﬁed
kinetically. Data were normalized with respect to the transparent values
and by subtracting the background.
2.7. Data analysis and data presentation
MSExcel andOrigin8were used for statistics, curve ﬁtting and graph
design. Unless otherwise stated, all data are presented as mean ± SEM.
RFU values tested in physiological conditions (blue curves/bars) were
set as control values. Signiﬁcance was tested using a student's t-test.
Signiﬁcant different values were indicated with *P b 0.05, **P b 0.01
and ***P b 0.001.
3. Results
3.1. Effect of pH on the interfacial adsorption and accumulation of LBPs
The pH in the ALF of healthy lungs is presumably the same as in the
capillaries surrounding the alveoli, between the values of venous
(pH 7.36) and arterial (pH 7.4) blood. In airways, it is reported that
abnormalities can occur during exo- and endogenous airways acidiﬁca-
tion/alkalinization (e.g. pollution, cystic ﬁbrosis, COPD) irrespective of
their etiology [36]. These critical factors may affect the pH in the ALF,
and thus, they may alter the electrostatic charges and surface potential
of the ALI. However, there are only few reports of direct pH measure-
ments in the ALF, all demonstrating slightly acidic conditions: e.g. pH
6.9 [38,39,43] but no physiological explanation thereof has been given
up to now. As shown in Fig. 2, acidic conditions completely blocked
the formation of an interfacial surfactant layer. To exclude a false nega-
tive result, we carefully tested whether BODYPI-PC ﬂuorescence is
sensitive to low pH, but this was not the case (data not shown). In
Fig. 2. Effect of pH (pH3–10) on LBPs. Left: Adsorption kineticswasmeasured for 60min, the ctrl condition is indicated in blue. Right: Startpoints (light gray bars) and endpoints (dark gray
bars) are shown. Maximal adsorption occurred at pH 7, acidic (pH ≤ 6) and alkaline conditions (pH ≥ 9) signiﬁcantly blocked LBPs adsorption.
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starting abruptly at pH of 7 with a following decrease that was signiﬁ-
cant at pH ≥ 9. In a following series of experiments (Fig. 3), we tested
pH values that are close within the physiological range (pH 6.2–7.8).
Slightly acidic solutions (pH 6.0–6.6) signiﬁcantly reduced surfactant
adsorption, whereas pH values of 7.0, 7.2 (n.s.), 7.8, and 8.0 promoted
it. As shown in Fig. 3, the pH inﬂuenced surfactant adsorption in a
biphasic manner, suggesting that the acid–base status might have
high signiﬁcance in lung function.
3.2. Effect of calcium
The physiological Ca2+ concentration in the alveoli is reported to be
1.5 mM [9,40], and thus, almost identical to plasma values (free Ca2+
concentration of about 1.25 mM). As for the pH, no data exist on the
possible range of concentrations in health and disease. Therefore, we
used Ca2+/EGTA buffered solutions between 0 and 5 mM. According
to our results, adsorption of LBPs was highest at a Ca2+ concentration
of 0.5 mM. By estimating initial adsorption rates as the slope between
the time points 1 and 3 min, we found that at 0.5 mM Ca2+ LBPs had
a faster adsorption rate in the beginning and reached a plateau phase
at 25 min. High calcium concentrations (5 mM) attenuated the adsorp-
tion kinetics. At this concentration the adsorption rate was signiﬁcantly
decreased, reaching a plateau at 25min, whichwas followed by a signal
reduction, probably due to partial desorption of surfactant material.
Notably, a Ca2+ concentration of zero had no signiﬁcant effect on the
spreading rate of LBPs (Fig. 4).
3.3. Effect of osmotic strength
The actual osmolarity of the ALF in healthy and diseased lungs is sub-
ject to controversy [18,51,63]. A reasonable assumption for ALFFig. 3. Effect of pH (pH 6.2–7.8) on LBPs. Left: Adsorption kinetics wasmeasured for 60min, the
gray bars) are shown. Maximal adsorption was occurred at pH 7.0 and 7.8, acidic conditions (posmolarity would be ~300 mOsm, about the same value than in blood
if passively regulated by Starling factors. However, due to the fact that
the alveolar epithelium is both, a secretory and resorptive tissue, large
deviations from this value could be expected as well. In addition, very
hypotonic and hypertonic conditions may occur during drowning of
fresh water and saltwater, for example. Here, we prepared solutions
between 0 and 600 mOsm by adjusting the NaCl concentration. As con-
trol we used a physiological saline with 300 mOsm. As can be seen in
Fig. 5, surfactant material adsorbs rapidly at the interface at low ionic
strength, while a reduction in the adsorption rate was observed at the
highest osmolarity values tested. Maximal adsorption occurred at
20 mOsm, and a minimum at 300 mOsm. At 20 mOsm we calculated
a steep, initial and almost linear slope up to 15 min that was followed
by a slight constant increase till the end of the measurement (Fig. 5).
3.4. Thermotropic effects
Pulmonary surfactant function is very sensitive to temperature,
which has been interpreted as a consequence of optimization of the
composition of surfactant membranes close to a critical transition. Sur-
factant would thus simultaneously optimize a dynamic behavior re-
quired for proper adsorption and re-spreading along the breathing
cycles and enough stability to sustain maximal pressures at the end of
exhalation [44,46]. Numerous studies have conﬁrmed the existence of
physiological mechanisms to ensure proper matching between surfac-
tant composition, structure and physiological temperature. For instance,
the group of Orgeig [59] analyzed native surfactants from heterothermic
animals to demonstrate that surfactant composition shifts to adapt to
lower body temperatures, probably to compensate the loss of function.
Whether such a temperature–function coupling is also pertinent in
freshly secreted LBPs collected from rats (a homeothermic mammal)
has not been determined yet. Temperature effects on the interfacialctrl condition is indicated in blue. Right: Startpoints (light gray bars) and endpoints (dark
H 6.2 and 6.4) signiﬁcantly reduced LBPs adsorption.
Fig. 4. Effect of Ca2+ concentration (0–5mM). Left: Adsorption kinetics was measured for 60 min, the ctrl condition is indicated in blue. Right: Startpoints (light gray bars) and endpoints
(dark gray bars) are shown. Maximal adsorption was occurred at 0.5 mM Ca2+, highest Ca2+ concentration (5 mM) signiﬁcantly reduced LBPs adsorption.
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cated T points (15 °C, 25 °C, 30 °C 37 °C and 42 °C) and not unexpected-
ly, temperatures below the body temperature signiﬁcantly diminished
surfactant adsorption rates and the same accounts for the initial adsorp-
tions rates at 42 °C (Fig. 6).
3.5. Effect of the presence of proteins
In ARDS, where the integrity of the alveolar-capillary permeability
barrier is impaired, albumin concentrations in the alveolar ﬂuid may
reach 100 mg/ml, with an average of 25 mg/ml as reported by Ishizaka
and coworkers [29]. We therefore tested the effect of the presence of
albumin on the interfacial adsorption and accumulation of material
from LBPs. The concentrations of albumin tested here are signiﬁcantly
lower than those typically found in ARDS patients, since we found that
they are still sufﬁcient to inhibit adsorption of LBPs. Our results revealed
a dose-dependent decrease in surface activity and a complete block at
2.5 mg/ml albumin (Fig. 7). These results are entirely in agreement
with many other reports using various other surfactant materials
[12,27,62].
3.6. Stability of LPBs
LBPs contain several different proteins, whereas the hydrophobic
surfactant proteins SP-B and, to a lesser extent, SP-C play crucial roles
in surface ﬁlm formation and stability during ﬁlm expansion and com-
pression [44,46]. Furthermore, we hypothesized that the strong pH-
dependency in LBP adsorption (Figs. 2 and 3) might reﬂect the contribu-
tion of pH-sensitive protein conformations or protein–lipid interactions
that are important for the adsorption of surfactant at the ALI. Consequent-
ly, any modiﬁcation of the proper conformation of these proteins shouldFig. 5.Effect of osmotic strength (0–300 mOsm). Left: Adsorption kineticswasmeasured for 60m
(dark gray bars) are shown. Maximal adsorption occurred at 20 mOsm, and a minimum at 300have a demonstrable effect. Thus, we used three different methods to
disrupt protein integrity in LBPs: trypsin proteolysis, mild urea treatment
[6] and mild soniﬁcation.
LBPs treated with 1% trypsin indeed showed a complete block in
adsorption, whereas 1 M urea leads to an increased ﬁlm formation by
LBPs. However pre-exposure of LBPs to cavitation-induced mechanical
forces (soniﬁcation with an ultrasonic bath from Elma, T420, with 70
peak/W high frequency) had no effect on their adsorption kinetics
(Fig. 8).
4. Discussion
The generally accepted view of the ALF is that of an exceedingly thin,
but most likely continuous layer of water, ranging in thickness from
several nanometers to micrometers with a tendency to be the thickest
in the septal corners [17]. Owing to the difﬁculties encountered in ana-
lyzing such a thin and dynamic layer and to sample it independently
from airway ﬂuids, its physical state and chemical composition are not
exactly known. Taking together the few available studies, the ﬂuid
volume of the hypophase is estimated to be ~0.1–5 ml/kg for humans,
with a lipid concentration of ~50 mg/ml [60] a Ca2+ concentration of
~1.5 mM and a pH of ~6.9 in healthy lungs [9,34,39]. An even greater
lack of information exists with respect to the possible deviations of
those parameters in pathophysiological situations and various lung
diseases. Due to that, most in vitro studies on biophysical surfactant
properties have been performed within a small set of standardized
conditions, in spite that alterations in the hypophase could have drastic
impacts on the surfactant ﬁlm formation and its performance at the ALI.
Here, we explored the potential effect of changes in the ALF during dis-
eased and healthy conditions on the dispersion, ﬁlm formation and ac-
cumulation of surfactant material as it is secreted by pneumocytes.in, the ctrl condition is indicated in blue. Right: Startpoints (light graybars) and endpoints
mOsm.
Fig. 6. Thermotropic effect. Left: Adsorption kinetics wasmeasured for 60min, the ctrl condition is indicated in blue. Right: Startpoints (light gray bars) and endpoints (dark gray bars) are
shown. Maximal adsorption occurred at 37 °C (body temperature), temperatures below body temperature diminished surfactant adsorption rates.
1847N. Hobi et al. / Biochimica et Biophysica Acta 1838 (2014) 1842–1850Recently, two studies reported a unique adsorption behavior of
freshly collected LBPs and demonstrated that native LBPs form highly
dynamic interfacial ﬁlms with deﬁned 2- and 3-D complexities [50].
These results suggest that surfactant may be transferred to the ALI in
the same compact form as it is released by the cells. This model gains
additional plausibility considering the fact that the mean size of LBPs
(1–3 μm) even surmounts the average thickness of the ALF (0.1 μm;
[5]), whichmeans that LBPsmay adsorb to the ALI almost at the instance
of extrusion through the exocytotic fusion pore. Despite the fact that the
distance between the site of cellular release and the ALI is ultimately
small, and the transit time probably ultimately fast, these particles are
exposed to the particular environmental conditions prevailing in the
ALF, which effects have been simulated in this study.
In vivo, pulmonary surfactant presents in manifold other structural
entities lacking amorphological similarity with compact LBPs, e.g. tubu-
lar myelin. Based on several lines of evidence, it can be concluded that
these structures are metabolically related to LBPs. However, it remains
an open question, whether tubular myelin is actually an extracellular
reservoir of surface material preceding adsorption or formed secondar-
ily as a consequence of dynamic ﬁlm expansion and compression, or by
interaction with surfactant proteins already present in the ALI, notably
SP-A (discussed in [17]). Hence, we concentrated our study at those
structures (LBPs), which are deﬁnitely as close as possible at the start
of the sequence of transformation processes, directly after release out
of the cells. In contrast to conventional methods used for evaluating
surface properties of pulmonary surfactant preparations, such as captive
bubble surfactometry or Langmuir balances, our method enables a
direct readout of the amount of surfactant adsorbing at the interface,
including the functionally important amount ofmaterialﬁrmly associat-
ed with the interfacial ﬁlm, in a medium-high sample throughput
manner. However, our assay has limitations, because neither directFig. 7. Effect of albumin protein concentration (0–2.5 mg/ml). Left: Adsorption kineticswasme
and endpoints (dark gray bars) are shown. Albumin concentration inhibited LBPs adsorption rmeasurements of surface tension nor modulations of the surface area
are possible.
4.1. Effect of pH
Little is known about the acid–base status of the ALF, probably due to
themetrological inaccessibility of the hyperthin and dynamic ﬂuid layer
[22,36,39]. Here, we describe a strong inhibitory effect of an acidic
milieu on LPBs adsorption. In an earlier study using a captive bubble
surfactometer, natural porcine surfactants containing surfactant pro-
teins showed, in contrast to artiﬁcial products, a relatively stable activity
over a broad pH-range [2]. Another study reported that the ability of
porcine native surfactant, and of preparations reconstituted from its
organic extract, to form surface active ﬁlms and reduce surface tension
to equilibrium, was impaired at alkaline but not at acidic pH [13]. It is
important to note that the ﬂuorescent method used in the present
experiments detects not only the interfacial adsorption of the limited
amount of material required to reduce surface tension to near equilibri-
um (~25 mN/m) but also the accumulation of an excess of material to
likely form a surface-associated reservoir. It could be possible that the
ultimate transfer of surface active lipids from the LBPs to the interface
is not somuch altered at acidic pH, but the ability of LBPs to stablymain-
tain an associationwith the surface ﬁlm. This should be explored further
in future work, because it is thought that the ability of an operative sur-
factant to form dense surface multilayers is important to sustain
interfacial stability along successive compression–expansion cycles
[8,46,55,57]. The relative impairment of interfacial adsorption at alka-
line pH has been previously attributed to the possible neutralization of
positive charges in SP-B and SP-C and the consequent loss of electrostat-
ic interactions with anionic lipids [13]. This could be also the reason for
the impairment of surface activity of LBPs. The dramatic loss of surfaceasured for 60min, the ctrl condition is indicated in blue. Right: Startpoints (light gray bars)
ate in a dose-dependent manner.
Fig. 8. Stability of LBPs. Adsorption of LBPs pretreated with 1% trypsin, 1 M urea and
soniﬁcation (70 peak/W) respectively. Proteolysis of LBPs signiﬁcantly decreases their
adsorptive capacity.
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particular structure of these assemblies, once they are secreted to the
extracellular milieu. It has been proposed that a progressive acidiﬁca-
tion of pH could be important for the maturation and assembly of sur-
factant membranes in the LBs, and that the neutralization of pH upon
secretion of LBs might convert LBPs into an adsorption competent
state [46,53]. Acidiﬁcation of LBP environment could therefore revert
some of these possible pH-triggered changes, making LBPs less prone
to unpack and spread upon adsorption at the interface. Our results
thus underline the crucial role of pH in the ALF and lay emphasis on
the critical monitoring of this parameter when evaluating surfactant
function. Further, these results may have implications to understand
the possible involvement of surfactant inactivation in patients suffering
of acid induced lung injury.
4.2. Effect of Ca2+
During the ﬁrst breath, the Ca2+ concentration in ALF increases
rapidly [16,37]. This extracellular Ca2+ rise seems to be themain source
for increased lung surfactant secretion [20,26,49]. Further, it is reported
that Ca2+ is required for tubular myelin assembly and stabilization in
the subphase, and enhances surfactant ﬁlm formation at the ALI by
interacting with the surfactant proteins and phospholipids [7,61].
Here, we demonstrate that adsorption kinetics of LBPs is unaffected by
Ca2+ concentrations between 0 and 2mM,while we observed an inhib-
itory effect at unphysiologically high concentrations (5mM). This result
is in agreement with earlier studies using the captive bubble, which
revealed that functionality of native porcine surfactant is relatively
independent on subphase Ca2+ concentration [9]. Thus, we propose
that a rapid Ca2+ rise after birth has its main physiological relevance
in the stimulation of surfactant secretion rather than in promoting
adsorption efﬁciency.
4.3. Effect of osmolarity
Several studies described the epithelial lining ﬂuid solute concentra-
tion in healthy conditions and different lung diseases like COPD, cystic
ﬁbrosis, and bronchial asthma [1,18,30,47]. For example in COPD
patients epithelial lining ﬂuid was isotonic (cations concentration
~150 mM), and not signiﬁcantly different from normal subjects [18].
In contrast, Quinton et al. reported a hypotonic condition in the lungs
from healthy patients and an isotonic line ﬂuid in patients with cystic
ﬁbrosis [47]. It is also reported that, in cystic ﬁbrosis, hypertonic saline
increases the volume of airway surface liquid, restoresmucus clearance,
and improves lung function. However, no data exist on surfactant func-
tion under varying osmotic conditions. Furthermore, whether such
osmotic changes might actually occur in the distal lung during e.g.lung disease induced hyperventilation and associated evaporative
water loss is still under dispute (see discussion in [15]). In this study
on adsorption of LBPs, we indeed observed a strong osmotic effect, as
hypotonic conditions promoted surfactant ﬁlm formation, whereas
hypertonic conditions had the opposite effect. We speculate that high
ionic strength could impair critical lipid–protein or protein–protein
electrostatic interactions that could be of importance to sustain LPB
adsorption and transformation at the interface.
4.4. Effect of temperature
Body temperature in humans, as in most homeothermic mammals,
is tightly regulated between 36.5 and 37.5 °C, but itmight change signif-
icantly during high or severe hypothermia. Values of 16 °C body tem-
perature have been documented in accidently hypothermic people
with successful resuscitation. During such condition, also the tempera-
ture in ALF changes signiﬁcantly, which might cause an impairment of
surfactant function [23]. Several studies already measured temperature
effect on surfactant activity [12,59]. As expected, normal body tempera-
ture (37 °C) favors LBPs adsorption, whereas cooling leads to a signiﬁ-
cant reduction. It has been proposed that surfactant composition,
including practically equivalent proportions of saturated and unsaturat-
ed phospholipids, may have evolved to sustain a coexistence of ordered
and disordered phases at physiological temperatures. These coexisting
phases would permit surfactant to simultaneously sustain two appar-
ently contradictory properties: a highly dynamic character, necessary
for very rapid adsorption and re-spreading at the interface, and enough
stability during compression at exhalation [4,14,44]. Adaptations to
seasonal low body temperature in hibernating animals actually include
changes in lipid composition to reduce the level of phospholipid satura-
tion in order to maintain rapid enough interfacial adsorption [59]. A
reduced accumulation of LBP material at low temperature could then
have to do with a reduced ﬂuidity of the most dynamic phases.
4.5. Protein inhibition and LBs stability
Inactivation of surfactant by serum leakage from the capillaries
during lung edema or acute lung injury is well documented in clinical
and biophysical studies [28,33,62,65]. Here, we have shown that a
small amount of BSA can also lead to a dramatic reduction of the capa-
bilities of LBPs to adsorb at the ALI, conﬁrming that leakage of serum
into the alveolar spaces may also compromise the transfer of freshly
secreted surfactant into a surface active ﬁlm. The inhibitory action of
serumproteins on the adsorption of different natural and clinical surfac-
tants has usually been interpreted as a consequence of the establish-
ment of a steric and electrostatic barrier between the surfactant and
the interface [62,65]. It remains to be established, whether inhibition
by serum of LPB adsorption is also due to a generic competitive effect
towards reaching the interface, or whether some of the components
leaked into serum could inhibit more speciﬁcally the machinery in
charge of “opening” and unraveling LBPs. To obtain additional informa-
tion about possible differences in the adsorption “machineries” of LBPs
and other surfactants, and their potential susceptibility to inactivating
environmental factors, we observed LBPs in respect to their sensitivity
to agents potentially affecting protein integrity. Trypsination and thus
full cleavage of the surfactant material completely blocked accumula-
tion of LBPmaterial at the ALI, whereas urea-promoted soft denaturation
even speeds up the adsorption rate. These ﬁndings support the general
hypothesis that surfactant proteins are crucial and irreplaceable in sur-
factant ﬁlm formation, even if they are available in low fraction like in
Curosurf (containing ~3.2 μg SP-B/μmol phospholipid and ~10.1 μg SP-
C/μmol phospholipid [9]). Surfactant proteins are therefore absolutely
required for triggering and promoting sufﬁcient interfacial surfactant
accumulation.
In summary, our results show that adsorption of LBPs and formation
of stably surface associated ﬁlms is highly sensitive to pH, temperature
1849N. Hobi et al. / Biochimica et Biophysica Acta 1838 (2014) 1842–1850and protein concentration. The systematic analysis by this sensitive
method of the capability of samples taken from patients to adsorb and
accumulate at the interface could therefore provide clues on the poten-
tial contribution of surfactant impaired performance to different pathol-
ogies. These ﬁndings, besides their relevance in lung physiology and
pathophysiology, may also have some implications in the design and
application of new surfactant compositions and surfactant therapies.
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